Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0150364003
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02511045 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02511045 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02511053 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02511053 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02511061 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Prescription | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
Marketed | 02511061 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
Approved | 02511088 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 10 MG / 0.2 ML |
Approved | 02511088 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Prescription | 1 | ADALIMUMAB | 10 MG / 0.2 ML |
Approved | 02511096 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Approved | 02511096 | PFIZER CANADA ULC | ABRILADA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02459299 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Prescription | 1 | ADALIMUMAB | 50 MG / ML |
Marketed | 02459299 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 50 MG / ML |
Marketed | 02459302 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 50 MG / ML |
Marketed | 02459302 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Prescription | 1 | ADALIMUMAB | 50 MG / ML |
Marketed | 02459310 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 50 MG / ML |
Marketed | 02459310 | AMGEN CANADA INC | AMGEVITA | Human | Yes | Prescription | 1 | ADALIMUMAB | 50 MG / ML |
Marketed | 02473097 | SAMSUNG BIOEPIS CO., LTD | HADLIMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02473097 | SAMSUNG BIOEPIS CO., LTD | HADLIMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02473100 | SAMSUNG BIOEPIS CO., LTD | HADLIMA PUSHTOUCH | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02473100 | SAMSUNG BIOEPIS CO., LTD | HADLIMA PUSHTOUCH | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02502380 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | Prescription | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
Marketed | 02502380 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | Schedule D | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
Marketed | 02502399 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02502399 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02502402 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02502402 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02492156 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02492156 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02492164 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02492164 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02505258 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Schedule D | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
Marketed | 02505258 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Prescription | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
Approved | 02502666 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Approved | 02502666 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02502674 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02502674 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02502682 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Marketed | 02502682 | FRESENIUS KABI CANADA LTD | IDACIO | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
Application information
Related information
Contact us
Version 4.0.3